Researchers Optimistic about Genomics Funding, Rate Illumina and Life Tech Best in Class
June 13, 2011
Researchers Optimistic about Genomics Funding, Rate Illumina and Life Tech Best in Class
A survey jointly conducted by GenomeWeb and Mizuho Securities also found that Illumina and Life Technologies are expected to collect the biggest bounty from any increase in NIH funding.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Funding Worries Ease Somewhat Among Genomics Researchers, Survey Finds
January 18, 2012 / GenomeWeb Daily News - Funding Optimism Grows Among Genomics Researchers, Mizuho Survey Finds
July 30, 2012 / GenomeWeb Daily News - Survey Indicates Life Tech Remains Leader of qPCR Research Market, But Faces Some Pricing Pressure
October 25, 2012 / PCR Insider - Survey Finds Mixed Funding Outlook Among Genomics Researchers
April 24, 2012 / GenomeWeb Daily News - Most Viewed Articles on GWDN Last Week
February 27, 2012 / GenomeWeb Daily News